These are the companies that we have served, and they are very happy with our service

About Us

Abiosciences is the US headquarters of Analytical Biosciences, a single cell genomics company focusing on accelerating the development of novel therapeutics. Its mission is to unlock the mechanism of diseases through the most advanced translational single cell platforms with the largest, high-resolution databases, and the most comprehensive commercial grade data analytics. Led by science and data, the company has been and will continue to generate new knowledge and compile/organize insights for the identification and validation of novel cellular targets and biomarkers, which ultimately lead to next generation breakthrough therapeutics and diagnostics.


Breaking news and amazing progress in science and development of Abiosciences.

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Oct 14th, 2021, Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that our client, Prof. Zhihua Liu’s group in Cancer Hospital of Chinese Academy of Medical Sciences, in close collaborations with Prof. Zemin Zhang’s group in Biomedical Pioneering Innovation Center of Peking University, has published a paper today about triple-negative breast cancer (TNBC) in Cancer Cell, a well-known academic journal in cancer research. Abio made great contributions to the single-cell sequencing experimental part of the study.

Read more

Professor Zemin Zhang wins the Natural Science First Prize of Beijing Science and Technology Award (2020)

On September 25, Beijing Science and Technology Award(2020)was publicly announced. Professor Zemin Zhang, a researcher at Biomedical Pioneering Innovation Center (BIOPIC) and Beijing Advanced Innovation Center for Genomics (ICG) of Peking University, the founder of Analytical BioSciences (Abio), won the first prize of the Natural Science Award for the project "Single Cell Atlas of Tumor Infiltrating T Cells".

Read more

The Shanghai R&D Center of Analytical BioSciences Officially Launched

On September 26th, 2021, Analytical BioSciences (Abio), a leader in single cell genomics, held the opening ceremony of its Shanghai R&D Center. Prof. Zemin Zhang, founder and scientific advisor of Abio, Mr. Tao Hong, co-founder and chief operation officer of Abio, Dr. Xiaodong Andy Huang, Senior Vice President of Abio, official leader of Xuhui District, representatives of investors including IDG Capital, Sequoia Capital China and SoftBank China, attended the ceremony to witness the milestone moment. The operation of the Shanghai R&D Center will greatly accelerate the drug R&D process and marks a new development stage of Abio.

Read more

Analytical Biosciences Named Finalist in IDC’s Inaugural Best in Future of Digital Infrastructure North America Awards

Analytical Biosciences and MemVerge implement world’s first Big Memory Computing environment for genomics research to fight cancer and stop the spread of COVID-19

Read more


Abiosciences provide several single cell solutions for scientific research and drug discovery/development.

Join Us

We are looking for best talents to join us in this transforming enterprise of biology and medicine. We encourage you to learn more about our company and explore our opportunities. 

Read more >

280 Utah Avenue Suite 110 South
San Francisco, CA 94080 United
Tel: +1-650-770-5619

© Analytical Biosciences Limited. All rights reserved.